You are using an older browser version. Please use a supported version for the best MSN experience.

FDA advisory panel to review Johnson & Johnson COVID-19 vaccine with thumbs up expected

A panel of expert advisers to the U.S. Food and Drug Administration is expected to recommend authorization of a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, setting the stage for the roll out of a third approved vaccine in the U.S. next week. Fred Katayama reports.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon